{"slideshow_credits": null, "snippet": "The third-largest U.S. health insurer said it would offer the drug as the preferred choice to its nearly 11 million commercial customers.", "abstract": "Aetna completes agreement with pharmaceutical company Gilead Sciences that will allow it to offer new hepatitis C treatment at a discounted rate to its nearly 11 million commercial customers.", "section_name": "Business Day", "print_page": "2", "document_type": "article", "byline": {"person": [], "organization": "REUTERS", "original": "By REUTERS", "contributor": ""}, "web_url": "http://www.nytimes.com/2015/01/17/business/aetna-and-gilead-reach-deal-on-hepatitis-c-drug.html", "lead_paragraph": "The third-largest U.S. health insurer said it would offer the drug as the preferred choice to its nearly 11 million commercial customers.", "headline": {"print_headline": "Aetna and Gilead Reach Deal on Hepatitis C Drug", "main": "Aetna and Gilead Reach Deal on Hepatitis C Drug", "content_kicker": "Business Briefing", "kicker": "Business Briefing"}, "_id": "54b9b8f138f0d83735b5a8a3", "word_count": "146", "multimedia": [], "pub_date": "2015-01-17T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Aetna Inc", "is_major": "Y", "rank": "1"}, {"name": "organizations", "value": "Gilead Sciences Inc", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Hepatitis", "is_major": "Y", "rank": "3"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "4"}], "blog": [], "subsection_name": null, "type_of_material": "Brief"}